Tomislav Kelava
Impact in
- Pharmacology top 10%
- Drug-Induced Hepatotoxicity and Protection
-
- Rheumatoid Arthritis Research and Therapies
Papers in
-
- Bone Metabolism and Diseases 9
- Epidemiology 10
- Liver Disease Diagnosis and Treatment 7
- Co-authors
- Ivan Ćavar (9 shared papers)Filip Čulo (7 shared papers)Danka Grčević (19 shared papers)Nataša Kovačić (16 shared papers)Vedran Katavić (8 shared papers)Roman Trobec (1 shared paper)Ivan Tomašić (1 shared paper)Zrinka Jajić (4 shared papers)
- Journals
- Frontiers in Immunology (4 papers)Medicine (2 papers)Molecules (2 papers)The FASEB Journal (1 paper)Seminars in Ophthalmology (1 paper)
- Partner nations
- CroatiaBosnia and HerzegovinaUnited States
In The Last Decade
Tomislav Kelava
46 papers receiving 588 citations
Peers
Comparison fields: 5 of 112
- Pharmacology 62
- Rheumatology 64
- Immunology 88
- Hepatology 29
- Oncology 89
Countries citing papers authored by Tomislav Kelava
This map shows the geographic impact of Tomislav Kelava's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomislav Kelava with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomislav Kelava more than expected).
Fields of papers citing papers by Tomislav Kelava
This network shows the impact of papers produced by Tomislav Kelava. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomislav Kelava. The network helps show where Tomislav Kelava may publish in the future.
Co-authors
The 25 scholars most cited alongside Tomislav Kelava, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 49 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 74 | |
| 2 | 2017 | 63 | |
| 3 | Biological actions of drug solvents | 2011 | 45 |
| 4 | 2018 | 45 | |
| 5 | 2014 | 43 | |
| 6 | 2010 | 39 | |
| 7 | 2010 | 26 | |
| 8 | 2020 | 18 | |
| 9 | 2021 | 16 | |
| 10 | 2019 | 16 | |
| 11 | 2016 | 15 | |
| 12 | 2020 | 15 | |
| 13 | 2020 | 14 | |
| 14 | 2014 | 13 | |
| 15 | 2015 | 11 | |
| 16 | 2018 | 10 | |
| 17 | 2020 | 10 | |
| 18 | 2009 | 9 | |
| 19 | The role of prostacyclin in modifying acute hepatotoxicity of acetaminophen in mice. | 2009 | 9 |
| 20 | 2021 | 8 |
About Tomislav Kelava
Tomislav Kelava is a scholar working on Molecular Biology, Epidemiology, Hepatology, Oncology and Pharmacology, having authored 49 papers that have together received 596 indexed citations. Recurring topics across this work include Bone Metabolism and Diseases (9 papers), Liver Disease Diagnosis and Treatment (7 papers), Drug-Induced Hepatotoxicity and Protection (6 papers), Liver Disease and Transplantation (5 papers), Cytokine Signaling Pathways and Interactions (4 papers), Bone health and osteoporosis research (3 papers), Regulation of Appetite and Obesity (3 papers) and Alcohol Consumption and Health Effects (3 papers). The work is most often cited by research in Pharmacology (62 citations), Rheumatology (64 citations), Immunology (88 citations), Hepatology (29 citations) and Oncology (89 citations). Tomislav Kelava has collaborated with scholars based in Croatia, Bosnia and Herzegovina and United States. Frequent co-authors include Ivan Ćavar, Filip Čulo, Danka Grčević, Nataša Kovačić, Vedran Katavić, Roman Trobec, Ivan Tomašić, Zrinka Jajić, Sanja Ivčević and Katarina Vukojević. Their work appears in journals such as Frontiers in Immunology, Medicine, Molecules, The FASEB Journal and Seminars in Ophthalmology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.